SA

Shaikh Asrar Ahmed

Active Director Director DIN 08330564
DIN 08330564 First appointment Jan 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Shaikh Asrar Ahmed

Data last updated:

Shaikh Asrar Ahmed is a Director at Was Pharma Private Limited (since 2019). The company operates in Chemicals. Was Pharma Private Limited reported revenue of ₹28,457 (FY 2020).

DIN 08330564
Primary Designation Director
Industry Chemicals
First Appointment 14 Jan 2019
Oldest Company Age 7 yrs
Largest company Was Pharma Private Limited · ₹28,457 (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Was Pharma Private Limited U24232UP2019PTC112300
Director14 Jan 20192019₹28,457 (FY 2020)Active

Board colleagues of Shaikh Asrar Ahmed

NameDINCompanyDesignation
Nasima08330566Was Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Was Pharma Private Limited
Premium access

Shareholding and investment profile for Shaikh Asrar Ahmed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shaikh Asrar Ahmed

Shaikh Asrar Ahmed currently holds 1 directorship: Was Pharma Private Limited (Director, since 14 Jan 2019, revenue ₹28,457 (FY 2020)).

Shaikh Asrar Ahmed was first appointed on 14 Jan 2019 as Director at Was Pharma Private Limited.

The current boards of Shaikh Asrar Ahmed's companies include Nasima (Was Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available